Lipocine is expecting to use the data from this trial to support a new drug application submission in mid-2026.

The postpartum depression scale also can't detect anxiety disorders, phobias, or personality disorders. Getting Help If you scored 10 or higher on EPDS screening, or you think you might have ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that the first ...

Mass. maternal health researchers want to expedite the detection of postpartum depression risk, starting in the delivery room ...

Postpartum depression is a clinical depressive episode that occurs in 13% to 20% of women after birth or miscarriage. This illness has potentially devastating consequences for both mother and ...

Having a baby affects everyone in the family, including fathers. Postpartum Support International says one in five moms and ...

A newly approved medication to treat postpartum depression will cost $15,900 per 14-day course, before insurance, when it reaches the market later this year, raising concerns among doctors and ...

“We do a really, really bad job of identifying and treating people with postpartum depression,” she said. Physicians administer surveys to assess current depression symptoms on the Edinburgh Postnatal ...

Data=Population Health and Welfare Association It was found that 30% of mothers in the early stages of twin births ...

Cite this: Use of the Postpartum Depression Screening Scale in a Collaborative Obstetric Practice - Medscape - Sep 01, 2007. ... Experiences of Women with Postpartum Depression 1.